LivaNova PLC is a global medical technology company that focuses on developing and delivering innovative solutions for patients with cardiovascular and neuromodulation disorders. They specialize in the design and manufacture of medical devices and therapies, including cardiac surgery systems, neuromodulation devices, and advanced circulatory support systems. LivaNova's products and therapies aim to improve patient outcomes, enhance quality of life, and provide effective treatment options for individuals with complex medical conditions.

The stock of LivaNova PLC, ticker symbol LIVN, is currently experiencing a messy trend and needs more time to form a base. A messy trend refers to a period of price action that lacks a clear and consistent direction, with frequent fluctuations and erratic movements. Forming a base refers to a period of consolidation and sideways movement in the stock price, where the price trades within a relatively narrow range. This base-building process often precedes a potential breakout or significant price movement.